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Abstract 
Anti-retroviral medication (ARV) adherence plays an important role in successful treatment 
outcome and preventing further transmission. However, stigma is recognized as an obstacle to 
achieve optimal ARV medication adherence. Previous studies suggest that self-compassion may 
play a role in self-regulation of health promotion, which may improve medication adherence. 
Also, self-compassion may be a protective factor in coping with stigma. The objectives of this 
study were 1) to examine the association between demographic characteristics and ARV 
medication adherence; 2) to examine the association between self-compassion and ARV 
medication adherence; 3) to examine the association between stigma and ARV medication 
adherence; 4) to examine whether self-compassion modifies the association between stigma and 
ARV medication adherence. A cross-sectional survey with 107 participants in Shanghai, China 
was used in this secondary data analysis, within which 88 participants reported currently being 
on ARV medication. Logistic regression was used to test the association between medication 
adherence and independent variables: demographic characteristics, stigma and self-compassion. 
Bivariate correlation between self-compassion and stigma was also examined. To examine 
interaction, the analysis of the association between stigma and adherence was stratified by self-
compassion. Participants who reported higher level of education, having health insurance, full 
time employment and enough income tended to be more adherent to medication. Categorical 
general perceived stigma was positively associated with adherence.  Self-compassion was not 
significantly related to medication adherence, but sensitivity analysis showed that if two outliers 
were excluded, self-compassion was associated with medication adherence (AOR 1.10, 95% CI 
1.00-1.21). Negative correlations were found between self-compassion and general perceived 
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stigma and between self-compassion and stigma subscales. However, no significant interaction 
was detected for self-compassion to modify the association between stigma and adherence. 
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Background 
HIV/AIDS has been transformed from a fatal disease to a chronic one with the coming 
and wide spread access to antiretroviral (ARV) medication. However, optimal medication 
adherence is needed to achieve successful viral suppression and immune restoration. Meanwhile, 
HIV-related stigma is not only associated with poor mental health but also commonly cited as a 
barrier for people living with HIV (PLWH) to practice optimal adherence. Self-compassion, on 
the one hand, may improve compliance to medical recommendations through enhancing self-
regulation; on the other hand, could buffer negative feelings and protect psychological 
functioning, which has an implication to counter negative effects of stigma. 
With the coming of ARV medication, morbidity and mortality of HIV infection has 
decreased largely (Palella et al., 1998). A cohort analysis of life expectancy change from 2000 to 
2007 in the United States of America (the USA) and Canada suggested that the life expectancy 
of a twenty-year-old HIV-infected person on ARV medication was approaching that of the 
general population (Samji et al., 2013). However, to benefit the most from treatment, medication 
adherence is important. Medication adherence is defined as "taking prescribed medications on-
time with correct dosage, and following corresponding restrictions in diet and lifestyles" 
(Osterberg and Blaschke, 2005; WHO, 2003). The purpose of adherence to medication is to keep 
the ARV concentration in the blood at a steady level that can suppress viral replication, as well 
as restore, maintain and enhance immune function, through which the disease progress is halted 
and HIV-related illness and death are prevented. While optimal adherence has been linked with 
better physical function, general health, social functioning and mental health (Wang et al., 2009), 
sub-optimal adherence may increase the risk of treatment failure (The US Department of Health 
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and Human Services, 2009 updated). Not being able to suppress viral load under the level of 
detection implies a risk of selection of drug-resistant strains and, consequently, limitations of 
treatment effectiveness as well as future medication selectivity (Chesney, 2003). In contrast, an 
undetectable viral load dramatically reduces the possibility of further HIV transmission (Attia et 
al., 2009). This finding has later translated into the “treatment as prevention” approach (Williams 
et al., 2011). Thus the importance of medication adherence is stressed in antiretroviral treatment 
programs.  
Nevertheless, adherence is not simply a take-it-or-not question. Although an ARV 
regimen is a life-saving treatment, taking ARV medication is a life-long activity, consisting of 
daily decisions made as a final result subjected to diverse external elements. To achieve optimal 
and sustained adherence thus depends on a consideration of a number of factors. Chesney (2000) 
pointed out that personal factors such as substance use, together with the nature and effects of 
medication as dietary restriction, inconvenient medicine-taking frequency, burden of pill count 
and side effects were inversely associated with medication adherence. Moreover, some 
contextual and environmental factors also contribute to poor adherence, such as low accessibility 
to medicines, lack of money for transportation, low quality of doctor-patient relationship, and 
social isolation (Rajabiun et al., 2007; Nam et al., 2008; Thrasher et al., 2008; Kip et al., 2009). 
Above all, HIV-related stigma is widely cited as one of the factors that constitutes a barrier to 
proper medication adherence (Rintamaki et al., 2006; Rao et al., 2007; Sabin et al., 2008; 
Dlamini et al., 2009; Katz et al., 2013). 
The definition of stigma varies. While Stafford and Scott (1986, as cited in Link and 
Phelan, 2001) suggested that stigma “is a characteristic of persons that is contrary to a norm of 
social unit,” Jones et al. (1984, as cited in Link and Phelan, 2001) indicated that stigma “is a 
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mark that links one to a stereotype.” Link and Phelan (2001) pointed out that the great variability 
in the definition of stigma was probably due to the concept being relevant in an enormous series 
of circumstances, from disability to mental illness, from sexual minorities to drug use; and that, 
hence, research on stigma was multidisciplinary. Contributions to the knowledge on stigma came 
from sociologists, anthropologists, psychologists and so on.  
As early described in Goffman's work (1963), stigma is a trait that has an extensively 
negative social implication – and is consequently discredited – in the cultural setting. If a person 
is known, be it by the public or by oneself, to possess this trait, the negative entailment of the 
trait is simultaneously attached to the individual. Disadvantageous consequences such as social 
disqualification, limited life opportunities, and negative change in social identity may thus be 
incurred (Berger et al., 2001). Steward and colleagues (2012) concluded that stigma is a 
systematic mechanism by which social interaction and behaviors are regulated. 
Accordingly, stigma is an interpersonal process as well as a social process that 
undermines health promotion. Corrigan (2004) addressed how stigma may affect whether a 
person with mental health problems who might benefit from treatment actually seeks treatment. 
He observed stigma as having two parts: public stigma, referring to public labels and attitudes 
toward mental illness; and self-stigma, which is the consequently negative self-image of being 
mentally ill. While public stigma deprives mentally-ill people from social opportunities, self-
stigma diminishes self-esteem and confidence in one's future. When seeking treatment becomes 
“evidence” that proves mental illness, it preclude those who suffer from mental illness from 
seeking treatment, in order to avoid the public labels and to escape from involving in self-
devaluation. 
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To capture how PLWH perceive, Berger et al. (2001) focused on the perspective of 318 
PLWH across the United States and provided a conceptualized model of perceived stigma. Given 
the individual's perception of societal attitudes toward PLWH and his or her personal feelings of 
being HIV infected, perceived stigma refers to the awareness of actual or potential 
disadvantageous consequences. After exploratory factor analysis (EFA), they identified four 
components that consist of perceived stigma – personalized stigma, disclosure concern, negative 
self-image and concern with public attitudes toward PLWH – as well as one single higher-order 
factor that could be conceptualized as general perceived stigma.  
Mental health problems and poor well-being have been found to be common among 
PLWH. A systematic review estimated that the prevalence of depression among PLWH on ARV 
medication was 34%, and that of anxiety was 28%. The prevalence of both was higher than in 
the general population (Lowther et al., 2014). Research suggests that poor mental health 
outcomes and well-being could be linked with stigma (Major and O’Brien, 2005). Berger and 
colleagues (2001) proposed that one may experience negative changes in self-image and 
emotional reactions toward those who stigmatize in response to stigmatization. According to 
Corrigan and colleagues (2004, 2006), the negative change in self-image – termed “self-stigma” 
– would diminish self-esteem and self-efficacy. Using a clinical sample of 221 HIV-positive men 
and women, Vanable et al. (2006) explored the relation between stigma-related experiences and 
depression. They pointed out that stigma was associated with depressive symptoms, after 
controlling for background characteristics and other correlates; consistently, those who reported 
higher stigma also received more psychiatric treatment within the preceding year. A similar 
finding was found in a survey of 229 PLWH in Southern India: it revealed that having 
experienced discrimination, perceiving stigmatizing attitudes from others, and self-stigma were 
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associated with high levels of depression (Steward et al., 2008). Furthermore, one study 
suggested that stigma would decrease medication adherence through damaging mental health. In 
a cross-sectional survey of 720 PLWH in the USA, Rao and colleagues (2012) found that poorer 
medication adherence was associated with higher level of stigma and depressive symptoms, and 
that depressive symptoms partially mediated the association between stigma and medication 
adherence. 
Self-compassion has been proposed as a psychological construct that describes how 
compassionate would one treat oneself when facing difficulties, such as failure or feeling 
inadequate (Neff, 2003a; Neff, 2003b),  and recent research on self-compassion suggests that it is 
associated with positive psychological functioning and general well-being (Neff, 2003a; Neff, 
2011; Neff et al., 2007a and 2007b; Leary et al., 2007).  In this light, self-compassion may play a 
role to enhance mental health. Also, it has been suggested as a factor that improves compliance 
to medical recommendations. Self-compassion entails three components: self-kindness, common 
humanity, and mindfulness. Self-compassion involves a desire to alleviate one’s suffering and to 
heal oneself with kindness through being receptive to and affected by one’s own suffering, rather 
than escaping or disconnecting from it. Self-compassionate people would offer a nonjudgmental 
understanding of their own pain, inadequacy and failure, so that their own faults and flaws could 
be seen in the broader aspect of shared human experience, whereby oneself – along with others – 
is acknowledged fully as a human being: limited and imperfect. Meanwhile, mindfulness – “a 
balanced state of awareness” of one’s emotions and general condition in reflection of the outside 
world (other individuals, community, and society) – also plays an important role in self-
compassion. Being objectively aware of one’s emotions allows one to avoid exaggerating or 
suppressing these emotions – neither running away from nor running away with the feelings 
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(Goldstein & Kornfield, 1987, as cited in Neff, 2003b). Not being dragged away by the emotions 
leaves space for self-kindness to occur and for a broader perspective to come into one’s view. 
Also, being aware of one’s general condition prevents one’s failing from unnoticed or neglected; 
rather, it reminds the person that some actions should be taken to improve well-being, yet in a 
tender and forgiving way (Neff, 2003b). 
Terry and Leary (2011) suggested that self-compassion would enhance self-regulation of 
health-related behavior. Self-regulation is a process that includes the following steps: 1) selecting 
health goals; 2) engaging in behaviors to reach the goals; 3) monitoring goal progress; 4) 
adjusting behavior or goals when sufficient progress is not being made (Baumeister and 
Heatherton, 1996, as cited in Terry and Leary, 2011). Self-compassion would help people set 
goals that are realistic, i.e. within and individual’s capability to achieve, as well as are targeted 
toward improving one’s well-being rather than fulfilling others’ expectations. It is also suggested 
that self-compassion is associated with conscientiousness, thus, instead of self-indulgence, self-
compassion is associated with self-initiated actions (Neff et al., 2007b), through which health 
goals can be reached. Moreover, self-compassion could predict adaptive emotional reactions 
(Neff et al., 2007a) and could mitigate negative feelings that drain out resources for self-
regulatory care, which implies a better compliance to medical recommendations (Brion and 
Menke, 2008). With mindfulness, which helps being aware of one’s own status, self-
compassionate people could pay more attention not only to their emotional fluctuations, but also 
their health problems, since research suggests that people with high self-compassion would seek 
advice from doctors sooner than those with low self-compassion (Terry et al., 2013). While 
people sometimes fall back to habitual behavior when establishing a behavior change, self-
compassion could facilitate reengagement in the establishing process, since self-compassionate 
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people may recognize that change is a process rather than a once-off thing. Therefore, they 
would be more likely to forgive their failures and to restart, instead of staying in self-criticism or 
giving up (Terry and Leary, 2011). In a self-compassionate approach, PLWH would realize that 
adhering to ARV medication is a way to stay healthy, so they would take steps to improve their 
well-being in spite of unpleasant habitual changes in daily life. The adaptive feature of self-
compassion was related to better adjustment, including lower stress, anxiety and shame in a 
sample of PLWH in the US (Brion et al., 2014), leaving self-compassionate PLWH with more 
regulatory resources to focus on medication adherence. When they occasionally miss a dose, 
instead of spending time on blaming themselves for their forgetfulness, they may be reminding 
themselves they are in a process, and take proactive action to prevent missing a dose from 
happening again.  
Studies have linked self-compassion with well-being and better mental health. Neff 
(2003a) carried out a survey on a sample of 391 undergraduate students in the USA and found 
that self-compassion had a negative correlation with anxiety and depression, as well as a positive 
correlation with life satisfaction. She later did another study with a sample of 232 undergraduate 
students in the USA to examine the relation between self-compassion and other self-attitudes and 
psychological constructs. It was suggested that self-compassion was related to self-esteem, yet 
differed from self-esteem in that self-esteem was significantly associated with narcissism, while 
self-compassion – one dimension of which is “common humanity” that emphasizes 
interconnectedness with others – did not express such self-centered and disassociating features. 
Besides, self-compassion was negatively associated with both rumination and thought 
suppression, which in turn comfirmed the negative correlation with depression (Wenzlaff and 
Luxton, 2003). Also, its positive association with emotional process coping indicates that self-
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compassion would be a helpful coping resource. Allen and Leary (2010) further elaborated the 
role of self-compassion in coping. They argued that self-compassion was related strongly to 
positive cognitive restructuring, which involves reframing one’s view of a stressful situation in 
less dire terms; and that it was negatively related to escape and avoidance, which were associated 
with negative psychological health (Penley et al., 2002).  
By the end of 2011, there were close to 445,000 PLWH being reported in China. Of these 
174,000 were diagnosed with AIDS, and 93,000 were reported death. It was epidemiologically 
estimated that 780,000 people were living with HIV, accounting for 0.06% of the total 
population. Sexual transmission was the primary mode of transmission. While the national 
prevalence remained low, the epidemic was concentrated in subgroups such as sex workers, men 
who have sex with men and drug users in some areas (UNGASS, 2012). In response to the 
HIV/AIDS epidemic, China government has implemented the “Four Frees and One Care” policy 
as early as 2003, in which ARV medication was offered for free for HIV/AIDS patients without 
insurance in urban areas and all patients in rural areas (Wu et al., 2007; Sun et al., 2010). The 
number of AIDS patients receiving ARV medication thus increased from 100 in 2003 to 80,000 
in 2009 (Sun et al., 2010). However, the expenditures for hospitalization and laboratory tests, 
such as CD4 counts and viral load, are not covered by the program. In addition, PLWH have to 
pay for transportation when they seek health services if they live far from the hospital (Starks et 
al., 2008). Through qualitative interviews with 29 PLWH receiving health care in Beijing, Starks 
and colleagues (2008) identified stigma and fear of discrimination as one of the barriers to 
medication adherence. Similarly, stigma and mental health issues, including HIV-related anxiety 
and feeling of isolation, were repeated themes in another qualitative study that took place in 
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Southern China (Sabin et al., 2008). Moreover, stigma was found to mediate the association 
between self-efficacy and medication adherence (Li et al., 2011).  
Statement of the problem 
Medication adherence is important for a successful treatment outcome of HIV infection. 
While free ARV medication is accessible in China, difficulties with adherence is one of the 
reasons for discontinuing treatment and development of drug resistance. Meanwhile, stigma 
remains an obstacle for PLWH to keep adhering to ARV medication. Self-compassion, on the 
other hand, may improve medication adherence through enhancing self-regulation and it may 
serve as a resource to cope with stigma and to mitigate the effect of stigma on mental health. 
Thus it may buffer the negative impact of stigma on medication adherence. 
Justification of study 
 Limited numbers of studies have examined the association between self-compassion, 
stigma and medication adherence, and even less in China.  More evidence is needed to examine 
the suggestions from previous research. This project is an attempt to expand the knowledge of 
self-compassion and add information to the literature, whereby future intervention could be 
informed if self-compassion is to be incorporated into HIV programs. Because the degree of self-
compassion is cultural sensitive and may differ from site to site (Neff et al., 2008; Birkett, 2014), 
previous study results from elsewhere may not reflect the situation in China. Thus they may not 
be useful to inform intervention. Information from study conducted in China is required. 
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Research question 
The research questions are “Is ARV medication adherence associated with self-
compassion and HIV-related stigma?” and “Does self-compassion modify the association 
between stigma and medication adherence?” 
Hypothesis 
It is hypothesized that 1) self-compassion is positively associated with ARV medication 
adherence; 2) higher level of stigma is negatively associated with ARV medication adherence; 
and 3) self-compassion would reduce the association between stigma and ARV medication 
adherence, namely, those who are more self-compassionate are more adherent to  medication 
than those who are less self-compassionate under the context of stigma. 
General objectives 
The goal of this project was to investigate the relationship among self-compassion, stigma 
and ARV medication adherence using a clinic sample of HIV infected people from Shanghai, 
China.  
Specific objectives 
The specific objectives were: 
1) to examine the association between demographic characteristics and ARV medication 
adherence;  
2) to examine the association between self-compassion and ARV medication adherence;  
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3) to examine the association between stigma and medication adherence;  
4) to examine whether self-compassion modifies the association between stigma and 
ARV medication adherence. 
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Methodology 
Participants and settings 
This study was based on a secondary analysis of data from a multisite cross-sectional 
survey conducted by the International Nursing Network for HIV/AIDS Research. The original 
study recruited PLWH from Canada, China, Namibia, Thailand, Puerto Rico and the USA. Only 
the participants from China were included in this analysis. 
Data were collected during November 2009 to March 2010 at the Shanghai Public Health 
Clinic Center (SPHCC), which is one of the specialist hospitals for HIV care in China. Potential 
study participants were approached directly by clinic staff during their hospitalization or routine 
visits and informed about the study; those who were interested were then referred to the 
researchers. To be enrolled in the study, participants had to meet the following criteria: 1) self-
reported HIV-positive serostatus; 2) age 18 years or older; 3) ability to provide informed consent. 
A total of 107 participants were recruited. After recruitment, screening for eligibility and 
obtainment of informed consent, participants were introduced to a computer-assisted interview.  
Instrument 
There were around 250 questions in the questionnaire. Other than those topics being 
utilized in current analysis, the questionnaire included topics such as engagement of health care 
provider, depression scale, anxiety scale, self-esteem scale, self-efficacy scale in relation to 
medication adherence and chronic disease, quality of life scale, sense of coherence scale, 
substance use assessment, and sexual risk behavior assessment. Participants took 40 minutes on 
average to accomplish the questionnaire. 
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The instrument was translated from English to Chinese. The translation process, through 
which the reliability of translated measures was ensured, involved forward translation by an 
expert whose native language was Chinese, and back translation. The translated questionnaire 
was reviewed, adjudicated and pilot tested by the research team. A consensus meeting was held 
to approve the translated version of the questionnaire (Rose et al. 2014). 
Measures 
Demographic background 
The questionnaire contained questions about the participants’ age, sex, race, education 
level, health insurance, having children or not, and work status. Participants were also asked 
which year they got infected, current CD4 count, as well as whether they had been diagnosed 
with AIDS. 
Stigma indicator 
The questionnaire included Berger’s 40 item Perceived Stigma Scale (PSS) (Berger et al., 
2001) and participants were asked to respond according to a four-point Likert scale, where 
1=strongly disagree, 2=disagree, 3=agree, and 4=strongly agree. Based on the data collected 
from Shanghai, an EFA was done and three factors were identified. At first, there were five 
factors with eigenvalue greater than one. After rotation and only retaining items with loading 
more than 0.5, no item was kept for the fifth factor, and only one item for the fourth factor. The 
only item that loaded 0.52 for the fourth factor simultaneously loaded 0.50 for the second factor. 
To simplify the analyses, a three-factor model was selected. These three factors altogether 
accounted for 75.3% of variance of the stigma data collected. 
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The three-factor model contains 30 items in total. As it is a three-factor model, three sub-
scales were developed. No positive stated item were included in sub-scales, thus sub-scale scores 
were generated by summing up all points of the items included in the scales. Higher score 
indicates higher stigma. The first scale, “experienced stigma,” captures respondents’ personal 
feelings or experiences of being mistreated because of having HIV. Sample items are “People 
don't want me around their children once they know I have HIV” and “People seem afraid of me 
once they learn I have HIV”. The second scale, “Fear of disclosure and public attitude,” indicates 
the respondents’ fear about the consequences of disclosure, or how they perceive the public 
attitude toward PLWH. For example, “Since learning I have HIV, I worry about people 
discriminating against me” and “Most people believe that a person who has HIV is dirty.” The 
third scale, “negative self-image,” refers to feeling dirty, ashamed or guilty because of having 
HIV. Items such as “Having HIV makes me feel unclean” fall under this sub-scale. There were 
13, 10 and 7 items in each sub-scale respectively; and the Cronbach alpha was 0.95, 0.94, and 
0.91, respectively. The association between medication adherence and the three factors was 
examined using binary logistic regression analysis. 
Since Berger’s 40 item PSS also is meant to measure a higher-order factor, 
conceptualized as “general perceived stigma,” the association between medication adherence and 
the overall score on the Berger scale was assessed. The overall score was calculated by reversing 
the score of positive stated items and then summing up the points of all the 40 items.  
The association between stigma and self-compassion and between stigma and medication 
adherence were assessed using binary logistic regression with continuous stigma scales (three 
subscales and one overall). To investigate whether stigma has an association with adherence in a 
non-linear way, stigma scores were also categorized. To categorize, plots with x-axis being 
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stigma score and y-axis being percentage of adherence were made for each continuous stigma 
scale. Then stigma was categorized depending on how the line graph was shaped to capture the 
non-linear features of each stigma scale. The line graph for experienced stigma was almost a 
horizontal line. The cut-off points were then set at the quartiles. There were four categories for 
each stigma scales, named “very low,” “low,” “high,” and “very high.” The cut-off points for 
each stigma scale are shown in Table 1.  
Table 1: Cut-off points for categorical stigma 
 Categories 
General perceived 
stigma 
Experienced stigma 
Fear of disclosure and 
public attitude 
Negative self-image 
Very low 46-85 13-22 10-20 7-12 
Low 86-105 23-32 21-26 13-18 
High 106-135 33-42 27-34 19-22 
Very high 136-152 43-52 35-40 23-28 
 
Self-compassion indicator 
A 12 item brief version of the Self-Compassion inventory (BVSCI) (Kemppainen et al., 
2013) derived from Neff’s 26 item Self-Compassion Scale (SCS) (Neff, 2003a) was used in the 
questionnaire. Analyzing data from 391 undergraduate students in the USA, Neff identified three 
factors and their corresponding counterparts – self-kindness versus self-judgment, common 
humanity versus isolation, and mindfulness versus over-identification – as six subscales in the 
full 26 items scale (Neff, 2003a). Leary invented a short version of this scale. Two items per 
subscale were selected based on their factor loading to make up the 12 item inventory. After 
validation with three non-clinical samples of 117 adult community members, 281 participants 
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from a psychological subject pool and 161 graduate students, the coefficient for the correlation 
between the short version and the original one was 0.92 and internal consistency was high for the 
short version with Cronbach’s alpha of 0.82 (Leary M, as cited in Kemppainen et al., 2013). 
For each of the 12 self-compassion items, the participants in the current survey were 
asked to grade how frequently they would deal with difficult situations in a certain manner on a 
five-point Likert scale, where 1=almost never, 2=rarely, 3=sometimes, 4=frequently and 
5=almost always. Sample items were “When I’m feeling down, I tend to obsess and fixate on 
everything that’s wrong,” and “When I’m going through a very hard time, I give myself the 
caring and tenderness I need.” The final score for each participant was generated by first 
reversing the points of negatively stated items and then summing up all the points for the 12 
items, giving a theoretical range from 12 to 60. The internal consistency reliability for the current 
sample was acceptable with Cronbach’s alpha being 0.77. 
ARV medication adherence 
Adherence to the prescribed ART medication was measured by the question “For the past 
30 days, what percent of the time were you able to take your medications exactly as your doctor 
prescribed them?” (Walsh et al., 2002) Participants made a mark on a visual analogue scale from 
0% to 100%, and then a percentage would be judged and interpreted by the computer. 
The initial plan was to use adherence as a continuous variable and employ linear 
regression. However, the density graph of the residuals of adherence did not fall close to the 
imposed normal distribution line (with the same mean and variance). Moreover, after running a 
linear regression model with adherence as the dependent variable and stigma as the independent 
variable, a plot of the observed versus predicted values (obtained using the command “regplot”) 
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revealed that the observed values of adherence were not symmetrically distributed around the 
predicted diagonal line. Another plot (obtained using the command “rvfplot2”) showed that the 
residuals for adherence against the predicted value were not distributed symmetrically around 
horizontal line of zero. The two above findings implied that the assumptions of linearity (an 
important assumption for linear regression) did not hold. Therefore adherence to medication was 
dichotomized into two groups. Those who reported 95% adherence or higher (Paterson et al., 
2000; Alcorn and Thaczuk, 2008) were conceptualized as optimal adherent, the rest as sub-
optimal adherent. 
Data analysis 
Percentages and averages were calculated to examine participants’ characteristics. 
Continuous variables such as age, duration of infection and CD4 counts were checked for 
whether normal distributed. If not, medians and ranges are presented. The Chi square test and the 
Wilcoxon-Mann Whitney test were used to examine gender differences for each demographic 
variable. The correlation between self-compassion and stigma were obtained using the command 
“corr”. Logistic regression was used to test the association between adherence and the 
independent variables: demographic variables, stigma and self-compassion. All odds ratios are 
presented as both crude OR and adjusted OR (controlled for sex, age and level of education). The 
assumptions of normality and linearity were checked for stigma and self-compassion, and were 
found to be hold. A sensitivity analysis for the association between self-compassion and 
adherence was conducted where participants with outlier values were excluded from the analysis, 
and locally weighted regression plots (LOWESS plots, obtained using the command “lowess”) 
were made to compare the associations with and without these participants. Each value on the 
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lowess curve is determined by neighboring data, thus the curve indicates the trend of the 
association between two variables. To examine whether there was any interaction between self-
compassion and stigma, the analysis of the association between stigma and adherence was 
stratified by self-compassion (higher or lower than mean value). The software STATA 13.0 was 
used for all statistical operations. 
Ethical considerations 
Informed consent was obtained from each study participant before enrollment. Computer-
assisted interview was used to ensure privacy. All study procedures in Shanghai were reviewed 
and approved by the institutional review boards of SPHCC. The University of California-San 
Francisco (UCSF) secured approval for the overall study data from each site, including Shanghai, 
China. Code numbers were used to protect the confidentiality of study participants. (Chen, Shiu, 
and Yang et al., 2013; Chen, Wantland, and Reid et al., 2013) 
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Results 
Participants’ characteristics 
Among a total of 107 participants, there were 90 (84%) males and 17 (16%) females. The 
age of the participants ranged from 23 to 59, with the median age being 36. One third of all held 
a bachelor degree or higher, 37% accomplished high school education, and 22% finished 
elementary education. Half of them reported having children. Forty-seven (44%) of them had no 
job when they took part in the survey, and 80 (75%) claimed to have no health insurance. The 
duration of being infected with HIV ranged from one to seventeen years, with the median being 
three years. Fifteen participants (14%) had been diagnosed with AIDS. The median CD4 count 
was 200 cells/mm3, ranging from 0 to 950 cells/mm3. Female participants were more likely to 
have health insurance and children.  
While seventeen participants (16%) had never taken ARV medication, eighty-eight (82%) 
participants stated that they were currently on ARV medication, and two (2%) had started taking 
ART yet had had stopped because of a recommendation from their health care providers. Thus 
only the 88 responses are used in medication adherence-related analyses. Among these 88 
participants, 75 (85%) were male and 13 (15%) were female. The distributions of other 
demographic characteristics for participants on ARV medication were comparable to all 
participants. However, while female participants on ART reported median age of 47, the median 
age of their male counterparts was 37. Females on ARV medication also reported two years 
longer median length of infection, less likely to have a full time job and more likely to have 
children than males on ARV medication.  
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Among the 88 participants who were currently on ARV medication, 53 (60%) were 
classified as optimally adherent, and 35 (40%) were classified as sub-optimally adherent. No 
significant gender difference was detected in adherence. 
Table 2: Participants’ demographic characteristics and categorical stigma 
Demographic variables Category Among total 107 
Among 88 who 
currently on ART 
Sex male 90 (84%) 75 (85%) 
 
female 17 (16%) 13 (15%) 
Race Han 100% 100% 
Education grade school  24 (22%) 19 (22%) 
 
high school 40 (37%) 35 (40%) 
 
technical/vocational school 8 (7%) 6 (7%) 
 
bachelor 32 (30%) 25 (28%) 
 
master 3 (3%) 3 (3%) 
Have children yes 52 (49%) 48 (55%) 
 
no 55 (51%) 40 (45%) 
Health insurance yes  27 (25%) 20 (23%) 
 
no 80 (75%) 68 (77%) 
Work status no work  47 (44%) 38 (43%) 
 
part time 17 (16%) 15 (17%) 
 
full time 43 (40%) 35 (40%) 
Income (self-report) inadequate 40 (37%) 34 (39%) 
 
barely adequate 48 (45%) 40 (45%) 
 
enough 19 (18%) 14 (16%) 
AIDS diagnosis yes 15 (14%) 13 (15%) 
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no 92 (86%) 75 (85%) 
On ART never 17 (16%) 0 
 
currently 88 (82%) 88 (100%) 
 
stopped 2 (2%) 0 
Age  median, range 36, 23-59 38, 24-59 
Duration of infection (year) median, range 3, 1-17 4, 1-17 
CD4 count median, range 200, 0-950 195, 4-950 
General perceived stigma Very low 11 (10%) 7 (8%) 
 
Low 24 (23%) 21 (24%) 
 
High 66 (62%) 54 (62%) 
 
Very high 5 (5%) 6 (6%) 
Experienced stigma Very low 4 (4%) 3 (3%) 
 
Low 30 (28%) 23 (26%) 
 
High 59 (56%) 50 (57%) 
 
Very high 13 (12%) 11 (13%) 
Fear of disclosure and public 
attitude 
Very low 9 (9%) 6 (7%) 
 
Low 15 (14%) 9 (10%) 
 
High 60 (57%) 54 (62%) 
 
Very high 22 (21%) 18 (21%) 
Negative self-image Very low 15 (14%) 10 (11%) 
 
Low 47 (44%) 40 (46%) 
 
High 31 (29%) 27 (31%) 
  Very high 13 (12%) 10 (11%) 
Note: for stigma scale of all participants, N=106; for stigma scale of participants on ARV medication, 
N=87. 
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All 107 participants reported on all items in the self-compassion scale. The mean self-
compassion score was 38.7 (SD = 6.1). On the stigma items, 106 participants reported (Table 3). 
No significant gender differences were found for self-compassion score, the score of general 
perceived stigma and the three sub-scales. The numbers and percentages of participants in each 
stigma category were illustrated in Table 2.  
Table 3: Stigma scores (N=106) 
  Mean SD Range No. of item 
General perceived stigma 109.8 19.2 46-152 40 
Experienced stigma 35.9 7.5 13-52 13 
Fear of disclosure and 
public attitude 
29.6 6.3 10-40 10 
Negative self-image 17 4.6 7-28 7 
 
Association and interaction analysis among variables 
Although none of the associations between ARV medication adherence and demographic 
variables were significant (Table 4), some tendencies can be seen. Those who reported higher 
level of education, having health insurance, full time employment, and enough income expressed 
higher ARV medication adherence. 
Table 4: Crude ORs and adjusted ORs for the association between demographic variables and adherence 
(N=88) 
Demographic variables Category 
No. (%) optimally 
adherent 
Crude OR (95% CI) Adjusted OR (95% CI) 
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Sex Male 44 (59%) Ref   
  Female 9 (69%) 1.59 (0.45-5.61) 1.86 (0.50-6.99) 
Education Grade school  11 (58%) Ref   
  High school 20 (57%) 0.97 (0.31-3.00) 0.90 (0.28-2.90) 
  Technical/vocational school 2 (33%) 0.36 (0.52-2.50) 0.32 (0.04-2.49) 
  Bachelor 17 (68%) 1.55 (0.45-5.33) 1.40 (0.37-5.21) 
  Master 3 (100%) - - 
Having children Yes 28 (58%) 0.84 (0.36-1.98) 1.16 (0.32-3.72) 
  No 25 (63%)     
Health insurance Yes  15 (75%) 2.37 (0.77-7.26) 2.04 (0.64-2.48) 
  No 38 (56%)     
Work status No work  21 (55%) Ref   
  Part time 8 (53%) 0.93 (0.28-3.07) 0.95 (0.27-3.41) 
  Full time 24 (69%) 1.77 (0.68-4.60) 1.69 (0.55-5.21) 
Income Inadequate 19 (56%) Ref   
  Barely adequate 25 (63%) 1.32 (0.52-3.34) 1.11 (0.38-3.22) 
  Enough 9 (64%) 1.42 (0.39-4.15) 1.02 (0.22-4.80) 
AIDS diagnosis Yes 7 (54%) 0.74 (0.22-2.41) 0.85 (0.25-2.87) 
  No 46 (61%)     
Age      0.99 (0.95-1.03) 0.99 (0.94-1.04) 
Duration of infection (year)     1.08 (0.93-1.25) 1.08 (0.93-1.26) 
CD4 counts     1.00 (0.998-1.004) 1.00 (0.998-1.004) 
 
Self-compassion was not associated with optimal medication adherence at the beginning, 
but the association became significant after excluding two participants with outlier value. The 
 - 31 -  
crude odds ratio for self-compassion was 1.09 (95% CI 0.999-1.18). After adjustment for sex, 
age and level of education, the odds ratio was 1.08 (95% CI 0.99-1.18). In other words, 
adherence tended to be higher with higher levels of self-compassion, but the association was not 
significant. We examined the relationship between self-compassion and adherence with a scatter 
plot and found two outliers: two participants with a self-compassion score of 30 (i.e. low) were 
optimally adherent. When we did a sensitivity analysis and excluded these two participants with 
outlier values, the adjusted odds ratio was 1.10, (95% CI 1.00-1.21; N=86). Two LOWESS 
curves showed the before-and-after difference clearly (Figure1a and 1b). Before the two 
participants were excluded, the curve indicated that, when self-compassion was within the range 
of 30-35, its association with adherence was negative; while when the self-compassion score was 
more than 35, its association with adherence was positive. When excluding two participants from 
the analysis, the association between self-compassion and adherence was positive.  
Figure 1a: LOWESS curve with all participants included 
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Figure 1b: LOWESS curve after excluding two participants 
  
Self-compassion was negatively associated with stigma (Table 5). It correlated inversely 
with “general perceived stigma,” “experienced stigma,” and “negative self-image”. However, 
self-compassion was not associated with “fear of disclosure and public attitude”.  
Table 5: Correlation between self-compassion and each stigma scale (N=106) 
  Correlation p-value 
General perceived stigma -0.20 0.037 
Experienced stigma -0.21 0.029 
Fear of disclosure and public attitude -0.01 0.851 
Negative self-image -0.40 0.000 
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A positive association was noticed between stigma and medication adherence. In the 
initial linear regression model, only the association between “fear of disclosure and public 
attitude” and adherence was significant. When using categorized stigma, the association between 
“general perceived stigma” and adherence became significant. Compared with the “very low” 
category, the other three categories (stigma score gets higher in order) had odds ratios of 15.93, 
9.88, and 23.23, respectively.  
When the sub-scales were categorized, the ORs for “experienced stigma” and “fear of 
disclosure and public attitude” were high, although the associations (except one) were not 
significant (Table 6a and 6b).  
Table 6a: Analysis between adherence and stigma as continuous variable (N=87) 
AOR (95% CI)  ARV medication adherence 
General perceived stigma 1.02 (0.99-1.04) 
Experienced stigma 1.04 (0.97-1.11) 
Fear of disclosure and public attitude 1.09 (1.01-1.19) 
Negative self-image 1.01 (0.92-1.11) 
 
Table 6b: Analysis between adherence and stigma as categorical variable (N=87) 
AOR (95%CI) General perceived stigma Experienced stigma 
Fear of disclosure and public 
attitude 
Negative self-image 
Very low Ref Ref Ref Ref 
Low 15.93 (1.51-167.75) 3.85 (0.28-52.15) 3.46 (0.26-45.31) 1.06 (0.25-4.54) 
High 9.88 (1.08-90.38) 4.21 (0.33-54.52) 9.89 (1.06-92.42) 0.66 (0.15-2.95) 
Very high 23.23 (1.07-504.86) 4.09 (0.26-64.62) 8.33 (0.76-91.35) 1.63 (0.25-10.52) 
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After stratifying by self-compassion score, we found that the high self-compassion group 
had a similar odds ratio as low self-compassion group for the association between medication 
adherence and stigma as continuous variable (Table 7a). However, when analyzing using stigma 
as categorical variable, distinctive odds ratios were observed between the two self-compassion 
groups (Table 7b), yet the confidence intervals overlapped. Hence, no interaction was detected. 
Table 7a: Interaction analysis of self-compassion and stigma (as continuous variable) on adherence 
AOR (95% CI) 
High self-compassion 
group 
Low self-compassion 
group 
General perceived stigma 1.03 (0.98-1.07) 1.02 (0.99-1.06) 
Experienced stigma 1.04 (0.94-1.15) 1.06 (0.97-1.16) 
Fear of disclosure and public attitude 1.13 (0.98-1.29) 1.07 (0.96-1.20) 
Negative self-image 1.04 (0.88-1.22) 1.05 (0.92-1.21) 
 
Table 7b: Interaction analysis of self-compassion and stigma (as categorical variable) on adherence 
AOR (95% CI) Category High self-compassion Low self-compassion 
General perceived stigma Very low  Ref Ref 
 
Low 5.31 (0.33-85.16) 2.33 (0.10-55.69) 
 
High 4.47 (0.28-72.51) 1.13 (0.06-22.26) 
 
Very high - - 
Experienced stigma Very low  Ref Ref 
 
Low 3.84 (0.16-94.73) 0.51 (0.07-3.70) 
 
High 2.71 (0.11-64.38) 0.99 (0.18-5.40) 
 
Very high 3.45 (0.09-129.00) - 
Fear of disclosure and public attitude Very low  Ref Ref 
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Low 0.25 (0.02-3.04) 1.42 (0.06-32.69) 
 
High 1.13 (0.17-7.45) 3.75 (0.35-40.30) 
 
Very high - 2.42 (0.16-36.68) 
Negative self-image Very low  Ref Ref 
 
Low 0.84 (0.12-6.08) 2.22 (0.16-29.80) 
 
High 1.86 (0.12-29.26) 1.27 (0.10-16.99) 
  Very high 0.76 (0.04-14.24) 5.05 (0.27-94.02) 
Note: omitted data was due to collinearity.  
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Discussion 
In this secondary analysis of data from a cross-sectional survey of 107 PLWH, a positive 
association between categorized general perceived stigma and medication adherence emerged. 
Sub-scale analysis indicated that this positive relation was mainly due to an association between 
"fear of disclosure and public attitude" and adherence. No association was found between self-
compassion and optimal ARV medication adherence, except after excluding two participants 
with outlier values. Self-compassion was negatively correlated with general perceived stigma, 
experienced stigma and negative self-image. No interaction between self-compassion and stigma 
on medication adherence was detected. Those who had higher level of education, health 
insurance, full time employment and adequate income tended to report higher adherence, but the 
associations were not significant.  
In the initial analysis, self-compassion was not associated with optimal adherence. In the 
sensitivity analysis in which two participants with outlier data were excluded, a significant 
positive association was found between self-compassion and optimal adherence. This finding 
indicated that self-compassion is related to health promoting behavior, which is aligned with 
previous studies (Terry et al., 2013; Brion et al., 2014). Terry and Leary (2011) suggested that 
self-compassion may boost health-related behavior through successful self-regulation, which 
involves setting a goal and engaging in behavior toward reaching that goal.  
In the context of ARV treatment, the goal would be to achieve successful viral 
suppression and to maintain immune function through appropriate adherence to medication. 
Adherence to medication does not merely mean “taking the medicine,” but requires taking the 
medicine on a specific time and in a specific way, which result in inconveniences for PLWH. 
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Also, negative feelings – such as anger, self-criticism of health status, self-blame for contracting 
disease or being reminded of HIV infection – may come along with medication and have 
negative impact on adherence (Brion and Menke, 2008; Brion, Menke and Kimball, 2013; 
MacDonell et al., 2013; Rintamaki et al., 2006). To respond to this predicament, self-kindness 
offers comfort to oneself to ease the pain and feelings of misfortune. The dimension referred to 
as “common humanity” may help to realize that the inconveniences incurred are experienced by 
lots of other PLWH, so that they would not feel isolated on the way to “reaching the goal.” 
Mindfulness may play a role that balances the rational and the negative emotions, for example, to 
find a balance between accepting the disease and self-denial; between benefits of medication and 
having to change habitual lifestyle; between starting to take medicine and staying in self-blame. 
In other words, self-compassion may buffer inconveniences, through which medication 
adherence may be enhanced. Therefore, the finding here is in line with Terry and Leary’s 
suggestion. 
When eliminating data from two participants who reported low self-compassion (score = 
30) with optimal adherence, a significant association emerged. Scrutinizing the other responses 
of the two participants with outlier data, one of the participants’ reported adherence was 
plausible, the other was questionable. One of the two reported very high adherence self-efficacy 
and fair CD4 count (330 cells/mm3), while the other one reported rather low adherence self-
efficacy and low CD4 count (90 cells/mm3), indicating either treatment failure or incorrect 
reporting of adherence.  
Examining how the participants’ demographic background was related to medication 
adherence, the tendencies that those who had better socioeconomic status and had health 
insurance would report higher adherence were in line with previous studies (Peltzer and Pengpid, 
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2013; Chen, Yang, and Liu, 2010). As PLWH have to pay out of pocket for transportation and 
lab and hospitalization fees, having health insurance to cover healthcare-related costs, as well as 
a full time job which could translate into adequate income, may improve ARV medication 
adherence. Level of education is usually related to not only having a full time job and income but 
also the level of health literacy (Van der Heide et al., 2013). The US Institute of Medicine (2004) 
defined health literacy as “the degree to which individuals have the capacity to obtain, process 
and understand basic health information and services needed to make appropriate health 
decisions.” Lack of health literacy may not merely be an obstacle to health information and 
health care, but lead to lack of knowledge to appropriately use medication (Nutbeam, 2008), 
whereby the association between level of education and medication adherence could be 
explained. 
A few studies suggest that self-compassion may buffer against negative self-feelings, 
including shame and concern with others’ judgments. Also, self-compassionate people tend to 
reframe a stressful situation in a more positive light and recognize their role in negative events 
without being overwhelmed by negative emotions (Leary et al., 2007; Allen and Leary, 2010; 
Brion et al., 2014). This indicates that self-compassion may play a role in countering stigma. 
However, previous studies examining the association between self-compassion and stigma are 
limited. The present analysis may be the first attempt to examine the association between self-
compassion and stigma among PLWH. Not surprisingly, self-compassion was negatively 
correlated with negative self-image, experienced stigma and general perceived stigma.  
Both the mistreatment that PLWH expect or experience as well as the perception of 
possessing discreditable attributes may lead to negative evaluation of oneself (Goffman, 1963, as 
cited in Berger et al., 2001). Yet, self-compassion, as relevant to emotional regulation and coping 
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(Neff, 2003b; Allen and Leary, 2010), may put up a protection against stigma. With mindfulness, 
people are more likely to be aware of their own emotions in a less harmful way when it arises. 
For example, some PLWH may feel guilty, unclean or find their infected body disgusting; and 
they often experience apprehension and rejection by others. Yet the non-judgmental, receptive 
and detaching features of mindfulness may allow them to sense and cognize this negative 
information without being drowned by the negative emotions incurred. This may help preclude 
them from being dragged away or ruminate in a negative circle. Besides, with self-kindness and 
a sense of common humanity, self-compassionate people may approach negative emotions with 
comfort and understanding (Neff, 2003a; Neff, 2003b). Instead of self-criticism and self-pity, 
self-compassionate people may treat themselves with sympathy – to realize that having negative 
emotions arising after being mistreated is reasonable; and to recognize that such negative events 
are a broad human experience, not only shared with other PLWH, but also with a variety of other 
marginalized groups. To sum up, self-compassion may serve an emotional regulating function 
when dealing with perceived stigma. The items in the subscales "experienced stigma" and 
"negative self-image," all refer to respondents' personal experiences and thoughts. Thus, the 
correlation detected between self-compassion and experienced stigma may be a result of 
experienced stigma negatively affecting an individual’s self-compassion. The causal direction 
could be the other way, i.e. those who are more self-compassionate may report less experienced 
stigma. However, as experiences are something that have already happened and in reality cannot 
be changed, we believe more in experienced stigma affecting self-compassion.  
The correlation between self-compassion and negative self-image may be due to some 
items in the “negative self-image” subscale reflecting characteristics of self-judgment and 
isolation, which are also part of self-compassion scale. Thus, the moderately strong inverse 
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correlation was predictable. On the contrary, the items measuring "fear of disclosure and public 
attitude" are focusing on attitudes and thoughts affecting HIV-infected people more in general. 
The findings indicate that self-compassion is more strongly related to personally felt stigma. 
One unexpected finding was that stigma was positively associated with medication 
adherence. In contrast, previous studies have cited stigma as a barrier to adherence in China 
(Starks et al., 2008; Sabin et al., 2008). However, the present positive association could be 
attributed to "fear of disclosure and public attitude." As this sub-scale captured how PLWH 
perceived public attitude, the higher scores may imply that the respondents cared more about 
others' opinion, whereby public discourse and others' opinion would have more influence on 
their behaviors. Therefore, one possible explanation for the positive association here could be 
that, it is the degree to which others’ opinion has an impact on PLWH’s behaviors that 
contributes to higher medication adherence. For example, “taking medicine” is generally 
regarded as a responsibility for someone who has disease, because a mature, independent adult 
should be responsible for taking care of him-/herself. In addition, in a cultural context that 
praises family responsibility as in China, taking medicine when having a disease is regarded as a 
responsibility not only for yourself but also for your family (Fredriksen-Goldsen et al., 2011). 
HIV infection would not be an exception, especially when the medication is offered for free, 
from which the public may hold an impression that there is no barrier to the access of medication. 
This discourse shapes those who adhere to medication as “good” patient and those who do not as 
“bad” patient. People who care more about others’ opinion or others’ valuing, would under this 
discourse practice higher adherence in order to be a “good” patient – take medicine for self and 
for family. 
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Secondly, although HIV/AIDS is a highly stigmatized disease, to be stigmatized requires 
being identified as a prerequisite. Infection with HIV is not a physical disability which can be 
recognized by appearance when a patient receives ARVs and responds well to the treatment. It 
needs a characteristic for the public to distinguish an infected individual from a “discreditable” to 
a “discredited” person. Ironically, taking ARV medication would invite a series of question that 
put PLWH in risk of disclosure, if not be recognized as a sign of having HIV. Therefore, if 
stigma here is conceptualized as disclosure concern, which refers to respondents’ efforts on HIV 
status control, and to escape the consequence of being known as an infected individual, another 
possible explanation of the positive association could be that, the more PLWH adhere to ARV 
medication, the higher is the risk they would be discovered as having HIV, thus, the more 
concern and fear they would have regarding the consequence of disclosure. People who are 
optimally adherent have to take the medicine at a specific time wherever they are, which exposes 
them and may lead to disclosure. Hence, those who reported higher adherence may also express 
more fear of consequence of disclosure. Similar results were found in Vanable and colleagues’ 
(2006) survey among a clinical sample of 221 PLWH in the USA in 2001-2002: people who 
disclosed their status to a broad range of social contacts experienced stigma more commonly.  
No significant interaction was detected to support the hypothesis that the association 
between stigma as a continuous variable and medication adherence would be different among 
PLWH with high self-compassion compared to those who were less self-compassionate. Yet 
when including stigma as a categorical variable, the two self-compassion groups had quite 
different AORs. Considering that this study was based on a small sample size, we cannot rule out 
that we could have found significant interaction if given a higher sample size. Nevertheless, the 
patterns of interaction differed across stigma subscales. High self-compassion seemed to 
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reinforce the positive association between general perceived stigma and medication adherence. 
The pattern for experienced stigma was similar to the pattern seen for general perceived stigma. 
In contrast, high self-compassion appeared to reduce the association between adherence and 
“fear of disclosure and public attitude”. In other words, hypothesis number 2 did not hold. It is 
difficult to explain the observed tendencies.  
 
Limitations 
There are several limitations of this study. Firstly, this study used a clinical sample of 107 
participants who attended the same HIV specialized hospital in Shanghai. The participants were 
likely to be a selected group of PLWH as they were motivated to respond to a questionnaire with 
250 questions. Also, since potential participants were recruited in a clinic, those who refused to 
return to the clinic or did not return regularly due to economic difficulties or other reasons would 
not have the possibility to be recruited. This non-random sample restricts the generalizability of 
the findings. Secondly, no causality can be concluded due to cross-sectional study design. 
Thirdly, the small sample size not only renders the analysis being very sensitive to extreme data 
points, and this may have been the case in the analysis of the association between self-
compassion and adherence; but also means less power to detect real differences between the 
groups. Fourthly, several potential biases may decrease the validity of the findings, such as recall 
bias and social desirability. For example, participants may have understood that optimal 
adherence was what the researchers wanted to adhere, whereby an incorrect adherence 
percentage may have been reported. Fifthly, although self-compassion was not significantly 
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associated with ARV medication adherence, it could be associated with other behaviors that the 
clients believe to be health promoting, such as Chinese medicine. 
 
Conclusion 
This study found that ARV medication adherence was positively associated with general 
perceived stigma, experienced stigma and fear of disclosure and public attitude. No association 
was found between self-compassion and adherence and between demographical variables and 
adherence. Self-compassion did not modify the association between stigma and adherence. 
 
Recommendations 
A larger sample size would help the analysis be less sensitive to outlier data. Participants 
could be recruited from several clinic settings and the data could be pooled to increase the 
generalizability. If the non-significant associations between demographic variables and 
adherence indicate real tendencies, PLWH without health insurance and full-time employment 
may need extra support to be adherent. Also, a detailed, clear and easily-understood medicine 
using instruction and HIV/AIDS care-related information could be prepared for PLWH with 
lower level of education in the case of lack of health literacy. As compassionate mindful training 
has been developed, it could be incorporated in ART programs to enhance medication adherence, 
or in mental health clinics for PLWH, those who suffer from stigma, to improve psychological 
functioning. Yet additional research is needed to replicate this study’s findings and to add 
information on the relationship between self-compassion, stigma and medication adherence. 
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Prospective study designs such as a cohort study may help to clarify the causal direction, and 
experimental design (compassionate mindfulness training intervention versus non-intervention) 
may provide information about the efficiency of self-compassionate training to improve 
medication adherence. 
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